TriVascular Technologies, Inc. (TRIV)

[PerserNL]

Huge potential for TRIV, will double according to analysts:

A number of equities research analysts recently issued reports on the stock. Bank of America initiated coverage on shares of Trivascular Technologies in a research report on Thursday, July 9th. They issued a “buy” rating on the stock. Credit Suisse reissued a “hold” rating and set a $8.00 price target (down previously from $10.00) on shares of Trivascular Technologies in a research report on Monday, August 10th. Canaccord Genuity reaffirmed a “buy” rating and issued a $13.00 target price on shares of Trivascular Technologies in a report on Wednesday, August 5th. BTIG Research reiterated a “buy” rating and issued a $8.00 price target on shares of Trivascular Technologies in a research note on Wednesday, August 5th. Finally, Zacks upgraded shares of Trivascular Technologies from a “sell” rating to a “hold” rating in a research report on Tuesday, July 7th.

Read more: http://www.financialwisdomworks.com/brokerages-set-trivascular-technologies-price-target-at-9-80-nasdaqtriv/24009/